HighMark Wealth Management »

Avita Therapeutics shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $32k 2.0k 16.03
2023-12-31 $27k 2.0k 13.72

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Us Vlu (IUSV)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Wells Fargo & Company (WFC)
Performant Finl (PFMT)
Eli Lilly & Co. (LLY)
Ishares Tr S&p 500 Val Etf (IVE)
Microsoft Corporation (MSFT)
Us Bancorp Del Com New (USB)
Paragon 28 (FNA)
Tela Bio (TELA)

View all positions for HighMark Wealth Management

Top funds holding Avita Therapeutics

Vanguard Group
AWM Investment Company
Bank of New York Mellon
Dimensional Fund Advisors
Soleus Capital Management
1492 Capital Management
Charles Schwab Investment Management
AQR Capital Management
D. E. Shaw & Co
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Two Sigma Advisers
Bank of America Corporation
Barclays
Rhumbline Advisers
Wellington Management Company

View all funds holding Avita Therapeutics